![Annovis Bio](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2020/02/Annovis-Bio.jpg?resize=735%2C400&ssl=1)
Groundbreaking Alzheimer’s Study Reveals Potential for Progression-Slowing Therapy
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has made a breakthrough in an ongoing study of Alzheimer’s disease. Their novel Alzheimer’s drug, buntanetap, which specifically targets neurotoxic proteins, has …
Groundbreaking Alzheimer’s Study Reveals Potential for Progression-Slowing Therapy Read More